Evidence map›Paper›PMID 34929159›Full record

ArticleExperimental eye research2022

Extracellular matrix dysfunction in Sorsby patient-derived retinal pigment epithelium.

Abbi L Engel, YeKai Wang, Thomas H Khuu, Emily Worrall, Megan A Manson, Rayne R Lim, Kaitlen Knight, Aya Yanagida, Jian Hua Qi, Aravind Ramakrishnan and 7 more

Open access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Gene therapy rescues cone function inMolecular therapy. Advances · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Metabolic Phenotyping of Healthy and Diseased Human RPE Cells.Investigative ophthalmology & visual science · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Abbi L EngelDepartment of Ophthalmology, University of Washington, Seattle, WA, 98109, USA.
YeKai WangDepartment of Ophthalmology, West Virginia University, Morgantown, WV, 26506, USA; Department of Biochemistry, West Virginia University, Morgantown, WV, 26506, USA.
Thomas H KhuuDepartment of Ophthalmology, University of Washington, Seattle, WA, 98109, USA.
Emily WorrallDepartment of Ophthalmology, University of Washington, Seattle, WA, 98109, USA.
Megan A MansonDepartment of Ophthalmology, University of Washington, Seattle, WA, 98109, USA.
Rayne R LimDepartment of Ophthalmology, University of Washington, Seattle, WA, 98109, USA.
Kaitlen KnightDepartment of Ophthalmology, University of Washington, Seattle, WA, 98109, USA.
Aya YanagidaDepartment of Ophthalmology, University of Washington, Seattle, WA, 98109, USA.
Jian Hua QiDepartment of Ophthalmic Research, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, 44106, USA.
Aravind RamakrishnanCenter for Blood Cancers and Oncology, St. David's South Austin Medical Center, Austin, TX, 78704, USA.
Richard G WeleberCasey Eye Institute, Oregon Health & Science University, Portland, OR, 97201, USA.
Michael L KleinCasey Eye Institute, Oregon Health & Science University, Portland, OR, 97201, USA.
David J WilsonCasey Eye Institute, Oregon Health & Science University, Portland, OR, 97201, USA.
Bela Anand-ApteDepartment of Ophthalmic Research, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, 44106, USA.
James B HurleyDepartment of Ophthalmology, University of Washington, Seattle, WA, 98109, USA; Department of Biochemistry, University of Washington, Seattle, WA, 98195, USA.
Jianhai DuDepartment of Ophthalmology, West Virginia University, Morgantown, WV, 26506, USA; Department of Biochemistry, West Virginia University, Morgantown, WV, 26506, USA. Electronic address: jianhai.du@wvumedicine.org.
Jennifer R ChaoDepartment of Ophthalmology, University of Washington, Seattle, WA, 98109, USA. Electronic address: jrchao@uw.edu.
University of Washington · USOregon Health & Science University · USCleveland Clinic · USWest Virginia University · USSt David's Medical Center · US

Funding

Vision Research CoreP30EY001730 · NEI · UNIVERSITY OF WASHINGTON · PI MAUREEN E NEITZ · 1985 to 2026
$23.5M
ROD AND CONE RESPONSE CHARACTERISTICSR01EY006641 · NEI · UNIVERSITY OF WASHINGTON · PI JAMES Bryant HURLEY · 1986 to 2026
$10.2M
RESOURCE/SERVICE CORE C - MOLECULAR INFORMATICS MODULEP30EY025585 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI BELA ANAND-APTE · 2016 to 2026
$7.7M
Control of Photoreceptor MetabolismR01EY017863 · NEI · UNIVERSITY OF WASHINGTON · PI JAMES Bryant HURLEY · 2007 to 2026
$6.4M
Regulation of Choroidal Neovascularization in Sorsby's Fundus DystrophyR01EY027083 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI ANAND-APTE, BELA · 2017 to 2024
$4.0M
Metabolic dysfunction from ECM remodeling in diseases of human RPER01EY034364 · NEI · UNIVERSITY OF WASHINGTON · PI Jennifer Rayming Chao, Jianhai Du · 2022 to 2026
$2.8M
Human RPE metabolism and metabolite transportR01EY026030 · NEI · UNIVERSITY OF WASHINGTON · PI CHAO, JENNIFER RAYMING, DU, JIANHAI · 2016 to 2020
$2.1M
Role of TIMP-3 in Ocular NeovascularizationR01EY016490 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI ANAND-APTE, BELA · 2005 to 2009
$1.7M
Role of betacellulin in diabetic macular edemaR01EY020861 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI ANAND-APTE, BELA · 2011 to 2014
$1.5M
Stem-Cell Properties of Human Corneal KeratocytesK08EY019714 · NEI · UNIVERSITY OF WASHINGTON · PI CHAO, JENNIFER RAYMING · 2010 to 2014
$1.1M
Respiration in vivo in the Retina and RPER21EY032597 · NEI · UNIVERSITY OF WASHINGTON · PI HURLEY, JAMES BRYANT · 2021 to 2022
$479k
BINDING OF EXPRESSED ARRESTIN TO RHODOPSINF32EY006641 · NEI · UNIVERSITY OF FLORIDA · PI POPP, MICHAEL P · 1995 to 1997
–
NEI NIH HHS F32 EY006641NEI NIH HHS K08 EY019714NEI NIH HHS P30 EY001730NEI NIH HHS P30 EY025585NEI NIH HHS R01 EY006641NEI NIH HHS R01 EY016490NEI NIH HHS R01 EY017863NEI NIH HHS R01 EY020861NEI NIH HHS R01 EY026030NEI NIH HHS R01 EY027083NEI NIH HHS R01 EY034364NEI NIH HHS R21 EY032597
6 · The paper itself

Abstract

Sorsby Fundus Dystrophy (SFD) is a rare form of macular degeneration that is clinically similar to age-related macular degeneration (AMD), and a histologic hallmark of SFD is a thick layer of extracellular deposits beneath the retinal pigment epithelium (RPE). Previous studies of SFD patient-induced pluripotent stem cell (iPSC) derived RPE differ as to whether these cultures recapitulate this key clinical feature by forming increased drusenoid deposits. The primary purpose of this study is to examine whether SFD patient-derived iPSC-RPE form basal deposits similar to what is found in affected family member SFD globes and to determine whether SFD iPSC RPE may be more oxidatively stressed. We performed a careful comparison of iPSC RPE from three control individuals, multiple iPSC clones from two SFD patients' iPSC RPE, and post-mortem eyes of affected SFD family members. We also examined the effect of CRISPR-Cas9 gene correction of the S204C TIMP3 mutation on RPE phenotype. Finally, targeted metabolomics with liquid chromatography and mass spectrometry analysis and stable isotope-labeled metabolite analysis were performed to determine whether SFD RPE are more oxidatively stressed. We found that SFD iPSC-RPE formed significantly more sub-RPE deposits (∼6-90 μm in height) compared to control RPE at 8 weeks. These deposits were similar in composition to the thick layer of sub-RPE deposits found in SFD family member globes by immunofluorescence staining and TEM imaging. S204C TIMP3 correction by CRISPR-Cas9 gene editing in SFD iPSC RPE cells resulted in significantly reduced basal laminar and sub-RPE calcium deposits. We detected a ∼18-fold increase in TIMP3 accumulation in the extracellular matrix (ECM) of SFD RPE, and targeted metabolomics showed that intracellular 4-hydroxyproline, a major breakdown product of collagen, is significantly elevated in SFD RPE, suggesting increased ECM turnover. Finally, SFD RPE cells have decreased intracellular reduced glutathione and were found to be more vulnerable to oxidative stress. Our findings suggest that elements of SFD pathology can be demonstrated in culture which may lead to insights into disease mechanisms.

Indexed as

Induced Pluripotent Stem CellsMacular DegenerationExtracellular MatrixHumansRetinal Pigment EpitheliumAge-related macular degenerationBasal laminar drusenCRISPR-Cas9 gene editingFundus dystrophy pseudoinflammatory of SorsbyInduced pluripotent stem cellsRetinal pigment epithelium

Identifiers

PMID34929159
PMCPMC8923943
OpenAlexW4220753782

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.